Trademark: 79246610
Word
ASCENTAGE PHARMA
Status
Registered
Status Code
700
Status Date
Tuesday, October 8, 2019
Serial Number
79246610
Registration Number
5876589
Registration Date
Tuesday, October 8, 2019
Mark Type
4000
Filing Date
Friday, August 10, 2018
Published for Opposition
Tuesday, July 23, 2019

Trademark Owner History
Jiangsu Ascentage Pharma Inc. - Original Registrant
JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC. - Owner At Publication

Classifications
5 Medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicines for dental purposes; antibiotics; pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oils; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; mineral food supplements; nutritional supplements
"PHARMA"

Trademark Events
Apr 1, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 1, 2024
Teas Change Of Correspondence Received
Apr 1, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 1, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 1, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 1, 2024
Teas Change Of Owner Address Received
Mar 27, 2023
Change Of Name/Address Rec'd From Ib
Dec 25, 2022
New Representative At Ib Received
Mar 13, 2020
Final Decision Transaction Processed By Ib
Feb 3, 2020
Generic Madrid Transaction Sent To Ib
Feb 3, 2020
Generic Madrid Transaction Created
Jan 8, 2020
Final Disposition Notice Created, To Be Sent To Ib
Oct 8, 2019
Registered-Principal Register
Jul 23, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Published For Opposition
Jul 3, 2019
Notification Of Notice Of Publication E-Mailed
Jun 14, 2019
Approved For Pub - Principal Register
Jun 13, 2019
Teas/Email Correspondence Entered
Jun 12, 2019
Correspondence Received In Law Office
Jun 12, 2019
Teas Response To Office Action Received
Jan 11, 2019
Refusal Processed By Ib
Dec 21, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Dec 20, 2018
Refusal Processed By Mpu
Dec 11, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 10, 2018
Non-Final Action Written
Dec 4, 2018
Application Filing Receipt Mailed
Nov 30, 2018
Assigned To Examiner
Nov 30, 2018
New Application Office Supplied Data Entered
Nov 29, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24